Accidental iatrogenic intoxications by cytotoxic drugs. Error analysis and practical preventive strategies

Drug Safety

Volumn 21, Issue 1, 1999, Pages 57-74

  Zernikow, Boris ^a,c   Michel, Erik ^b   Fleischhack, Gudrun ^a   Bode, Udo ^a  

^a UNIVERSITY HOSPITAL BONN   (Germany)

^b UNIVERSITY OF AMSTERDAM   (Netherlands)

^c UNIVERSITY OF WITTEN HERDECKE   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOTOXIC AGENT;

ARTICLE; DRUG FATALITY; DRUG INTOXICATION; HUMAN; IATROGENIC DISEASE; MODEL; PRIORITY JOURNAL;

ANTINEOPLASTIC AGENTS; CHILD; CHILD, PRESCHOOL; ENDODERMAL SINUS TUMOR; HUMANS; IATROGENIC DISEASE; INFANT; LEUKEMIA, LYMPHOCYTIC, ACUTE; MALE; TESTICULAR NEOPLASMS;

EID: 0032868278     PISSN: 01145916     EISSN: None     Source Type: Journal    
DOI: 10.2165/00002018-199921010-00005     Document Type: Article

References (170)

1. 1. American Society of Hospital Pharmacists, American Medical Association, American Nurses Association, American Society of Hospital Pharmacists. Understanding and preventing drug misadventures. Proceedings of a multidisciplinary in vitational conference; 1994 Oct 21-23. Am J Health Syst Pharm 1995; 52: 369-416
2. 1. American Society of Hospital Pharmacists, American Medical Association, American Nurses Association, American Society of Hospital Pharmacists. Understanding and preventing drug misadventures. Proceedings of a multidisciplinary in vitational conference; 1994 Oct 21-23. Am J Health Syst Pharm 1995; 52: 369-416
3. 2. Addiego JE Jr, Ridgway D, Bleyer WA. The acute management of intrathecal methotrexate overdose: pharmacologic rationale and guidelines. J Pediatr 1981; 98: 825-8
4. 3. AI Fawaz IM. Fatal myeloencephalopathy due to intrathecal vincristine administration. Ann Trop Paediatr 1992; 12: 339-42
5. 4. Anonymous. Inquests - MEq-Mg mix-up 'lead to death'. Pharm J 1977; 219: 139
6. 5. Arico M, Nespoli L, Porta F, et al. Severe acute encephalopathy following inadvertent intrathecal doxorubicìn administration. Med Pediatr Oncol 1990; 18: 261-3
7. 6. Attilio RM. Caring enough to understand: road to oncology medication error prevention. Hosp Pharm 1996; 31: 17-26
8. 7. Baer MR, King LE, Wolff SN. Palmar-plantar erythrodysesthesia and cytarabine. Ann Intern Med 1985; 102: 556
9. 8. Bain PG, Lantos PL, Djurovic V, et al. Intrathecal vincristine: a fatal chemotherapeutic error with devastating central nervous system effects. J Neurol 1991; 238: 230-4
10. 9. Barna P. Vincristin overdose [letter]. Clin Pediatr (Phila) 1980; 19: 440
11. 10. Beer M, Cavalli F, Martz G. Vincristine overdose: treatment with and without leucovorin rescue [letter]. Cancer Treat Rep 1983; 67: 746-7
12. 11. Berenson MP. Recovery after inadvertent massive overdose of vincristin (NSC-67574). Cancer Treat Rep 1971; 55: 525-6
13. 12. Bleck TP, Jacobsen J. Prolonged survival following the inadvertent intrathecal administration of vincristine: clinical and electrophysiologic analyses. Clin Neuropharmacol 1991; 14: 457-62
14. 13. Brahams D. Medicine and the law. Manslaughter and reckless medical treatment. Lancet 1991; 338: 1198-9
15. 14. Brivet F, Pavlovitch JM, Gouyette A, et al. Inefficiency of early prophylactic hemodialysis in cis- platinum overdose. Cancer Chemother Pharmacol 1986; 18: 183-4
16. 15. Cancer center airs investigators' findings on overdose incidents, cites subsequent system changes. Am J Health Syst Pharm 1995; 52: 2631-2
17. 16. Casteels-Van-Daele M, Beirinckx J, Baines P. Overdose with vincristine. J Pediatr 1977; 90: 1042-3
18. 17. Chagnon A, Jean P, Hautville D, et al. Accidents toxiques aigus dus à F administration accidentelle d'une dose excessive de vincaleucoblastine. MM No. 107 Sept./2
19. 18. Choonara IA, Kendall-Smith S, Bailey CC. Accidental actinomycin D overdose in man, a case report. Cancer Chemother Pharmacol 1988; 21: 173-4
20. 19. Chu G, Mantin R, Shen YM, et al. Massive cisplatin overdose by accidental substitution for carboplatin: toxicity and management. Cancer 1993; 72: 3707-14
21. 20. Coates TD. Survival from melphalan overdose. Lancet 1984; 11: 1048
22. 21. Cohen MR. Medicatìon error reports. Hosp Pharm 1977; 12: 100-1
23. 22. Cohen MR. Medication error reports. Hosp Pharm 1990; 25: 266-7
24. 23. Cohen MR. Safety alert - overdose of phatinol (cisplatin) and paraplatin (carboplatin) and a dangerous abbreviation. Hosp Pharm 1992; 27: 991-2
25. 24. Cohen MR. Adria, a dangerous abbreviation for adriamycin, looks like aredia. Hosp Pharm 1994; 29: 141-58
26. 25. Cohen MR. Another vincristine tragedy: what are you doing to make sure this doesn't happen to you? Hosp Pharm 1994; 29: 725-6
27. 26. Cohen MR. Accidental overdose of investigational drug because of a misunderstood label. Hosp Pharm 1995; 30: 70-3
28. 27. Cohen MR. Preventing daunorubicin (cerubidine) -doxorubicin mix-ups. Hosp Pharm 1996; 31: 184-7
29. 28. Cohen MR. Liposumal doxorubicin formulation confused with conventional doxorubicin. Hosp Pharm 1997; 32: 44-51
30. 29. Conter V, Rabbone ML, Jankovic M, et al. Overdose of vinblastine in a child with Langerhans' cell histiocytosis: toxicity and salvage therapy. Pediatr Hematol Oncol 1991; 8: 165-9
31. 30. Curran CF. Acute doxorubicin overdoses [letter]. Ann Intern Med 1991; 115: 913-4
32. 31. Czaykowski PM, Samuels T, Oza A. A durable response to cytarabine in advanced breast cancer. Clin Oncol 1997; 9: 181-3
33. 32. Dyke RW. Treatment of inadvertent intrathecal injection of vincristine [letter]. N Engl J Med 1989; 321: 1270-1
34. 33. Ettinger LJ, Freeman AI, Creaven PJ. Intrathecal methotrexate overdose without neurotoxicity: case report and literature review. Cancer 1978; 41: 1270-3
35. 34. Ettinger LJ. Pharmacokinetics and biochemical effects of a fatal intrathecal methotrexate overdose. Cancer 1982; 50: 444-50
36. 35. Fassoulaki A, Pavlou H. Overdosage intoxication with cisplatin-a cause of acute respiratory failure. J R Soc Med 1989; 82: 689
37. 36. Fernandez MN, Cabrera R, Sanjuan I, et al. Hypertension, grand mal epilepsy, intestinal dyskinesia, sensitive motor neuropathy and hyponatremia resulting from acute vincristine overdose. Sangre 1981; 26: 200-15
38. 37. Florentino MV, Salvagno L, Chiarion Sileni V, et al. Vindesine overdose [letter]. Cancer Treat Rep 1982; 66: 1247-8
39. 38. Fritsch J. Syracuse hospital admits causing death of patient. New York Times 1992, May 13: B5
40. 39. Gaidys WG, Dickermann JD, Walters CL, et al. Intrathecal vincristine. Report of a fatal case despite CNS washout. Cancer 1983; 52: 799-801
41. 40. Gebbia V, Palmeri S, Russo A, et al. Toxicity secondary to cis-diamminedichloro-platinum overdose: a case report. Int J Exp Clin Chemother 1989; 2: 219-24
42. 41. Grush OC, Morgan SK. Folinic acid rescue for vincristine toxicity. Clin Toxicol 1979; 14: 71-8
43. 42. Hachimi-Idrissi S, Schots R, DeWolf D, et al. Reversible cardiopathy after accidental overdose of mitoxantrone. Pediatr Hematol Oncol 1993; 10: 35-40
44. 43. Hanson DS, Leggette Ct. Severe hypotension following inadvertent intravenous administration of interferon alpha 2a. Ann Pharmacother 1997; 31: 371-2
45. 2) in an infant with rhabdomyosarcoma. Anticancer Res 1989; 9: 427-8
46. 45. Jakobson AM, Kreuger A, Mortimer O, et al. Cerebrospinal fluid exchange after intrathecal methotrexate overdose: a report of two cases. Acta Paediatr 1992; 81: 359-61
47. 46. Jardine LF, Ingram LC, Bleyer WA. Intrathecal leucovorin after intrathecal methotrexate overdose. J Pediatr Hematol Oncol 1996; 18: 302-4
48. 47. Jochimsen PR. Subacute vincristine toxicity following five consecutive doses. Am J Clin Oncol 1982; 5: 437-41
49. R): Symptome und Behandlung. Eine Übersicht. Onkologic 1990; 13: 96-101
50. 49. Jungi WF. Häufige Fehler bei der Planung und Durchführung von Tumortherapien. Schweiz Rundsch Med Prax 1991; 80: 196-9
51. 50. Kaufman IA, Kung FH, Koenig HM, et al. Overdose with vincristine. J Pediatr 1976; 89: 671-4
52. 51. Kim IS, Gratwohl A, Stebler C, et al. Accidental overdose of multiple chemotherapeutic agents. Korean J Intern Med 1989; 4: 171-3
53. 52. Kosmidis HV, Bouhoutsou DO, Varvoutsi MC, et al. Vincristine overdose: experience with 3 patients. Pediatr Hematol Oncol 1991; 8: 171-8
54. 53. Lafolic P, Liliemark J, Björk O, et al. Exchange of cerebrospinal fluid in accidental intrathecal overdose of cytarabine. Med Toxicol Drug Exp 1988; 3: 248-52
55. 54. Lampkin BC, Higgins GR, Hammond D. Absence of neurotoxicity following massive intrathecal administration of methotrexate. Cancer 1967; 20: 1780-1
56. 55. Langslow A. Nursing and the law. Carelessness in cancer care. Aust Nurs J 1996; 4: 32-1
57. 56. Laskoski G. Fatal mixup. Am Drug 1992; 205: 15
58. 57. Lau G. Accidental intraventricular vincristine administration: an avoidable iatrogenic death. Med Sci Law 1996; 36: 263-5
59. 58. Leblanc T, Chevallier B, Doz F, et al. Injection intrathécale accidentelle d'une forte dose de méthotrexate: proposition d'un schéma thérapeutique à propos d'une observation. Ann Pediatr Paris 1987; 34: 453-4
60. 59. Lee ACW, Wong KW, Fong KW, et al. Intrathecal methotrexate overdose. Acta Paediatr Int J Paediatr 1997; 86: 434-7
61. 60. Lindahl CE. Överdosering - dödsfall. Vardfacket 1979; 3: 73
62. 61. Lotz JP, Chapiro J, Voinea A, et al. Overdosage of vinorelbine in an women with metastatic non-small tell lung carcinoma. Ann Oncol 1997; 8: 714-5
63. 62. Maeda K, Ueda M, Ohtaka H, et al. A massive dose of vincristine. Jpn J Clin Oncol 1987; 17: 247-53
64. 63. Manelis J, Freudlich E, Ezekiel E, et al. Accidental intrathecal vincristine administration: report of a case. J Neurol 1982; 228: 209-13
65. 64. Michelagnoli MP, Bailey CC, Wilson I, et al. Potential salvage therapy for inadvertent intrathecal administration of vincristine. Br J Haematol 1997; 99: 364-7
66. 65. Montauk L. Doctors and manslaughter [letter]. Lancet 1991; 338: 1599
67. 66. Morrissey J. State probe shows Dana-Farber failed to follow basic protocols. Mod Healthe 1995; 25: 82-4
68. 67. Mortensen ME, Cecalupo AJ, Lo WD, et al. Inadvertent intrathecal injection of daunorubicin with fatal outcome. Med Pediatr Oncol 1992; 20: 249-53
69. 68. O'Marcaigh AS, Johnson CM, Smithson WA, et al. Successful treatment of intrathecal methotrexate overdose by using ventriculolumbar perfusion and intrathecal instillation of carboxypeptidase G2. Mayo Clin Proc 1996; 71: 161-5
70. 69. Pìerga JY, Bcuzeboc P, Dorval T, et al. Favourable outcome after plasmapheresis for vincristine overdose [letter]. Lancet 1992; 340: 185
71. 70. Pike IM, Arbus MH. Cisplatin overdose. Oncol Nurs Forum 1992; 19: 1163
72. 71. Robbins G. Accidental intrathecal injection of vindesine. BMJ 1985; 291: 1094
73. 2 of cisplatin. Am J Med 1989; 86: 624-5
74. 73. Schochet SS, Lampert PW, Earle KM. Neuronal change induced by intrathecal vincristine sulfate. J Neuropathol Exp Neurol 1968; 27: 645-58
75. 74. Sheikh-Hamad D, Timmins K, Julali Z. Cisplatin-induced renal toxicity: possible reversal by n-acetylcysteine treatment. J Am Soc Nephrol 1997; 8: 1640-4
76. 75. Shepherd DA, Steuber CP, Starling KA, et al. Accidental intrathecal administration of vincristine. Med Pediatr Oncol 1978; 5: 85-8
77. 76. Siegert W, Hiddemann W, Koppensteiner R, et al. Accidental overdose of mitoxantrone in three patients. Med Oncol Tumor Pharmacother 1989; 6: 275-8
78. 77. Slimowitz R. Thoughts on a medical disaster. Am J Health Syst Pharm 1995; 52: 1464-5
79. 78. Slyter H, Liwniez B, Herrick MK, et al. Fatal myeloencephalopathy caused by intrathecal vineristine. Neurology 1980; 30: 867-71
80. 79. Spiegel RJ, Cooper PR, Blum RH, et al. Treatment of massive intrathecal methotrexate overdose by ventriculolumbar perfusion. N Engl J Med 1984; 311: 386-8
81. 80. Stahel RA, Oelz O. Syndrome of inappropriate ADH secretion secondary to vinblastin. Cancer Chemother Pharmacol 1982; 8: 253-4
82. 81. Steger GG, Mader RM, Gnant MFX, et al. GM-CSF in the treatment of a patient with severe methotrexate intoxication. J Intern Med 1993; 233: 499-502
83. 82. Stones DK. Vincristine overdosage in paediatric patients. Med Pediatr Oncol 1998; 30: 193
84. 83. Suskind RM, Brusilow SW, Zehr J. Syndrome of inappropriate secretion of antidiuretic hormone produced by vincristine toxicity (with bioassay of ADH level). J Paediatr 1972; 81: 90-8
85. 84. Takada SI, Chen SZ, Mori H. Toxicity of vincristine overdose in a patient with invasive mole. J Jpn Soc Cancer Ther 1989; 24: 2617-23
86. 85. Thomas LL, Braat PC, Somers R, et al. Massive vincristine overdose: Failure of leucovorin to reduce toxicity. Cancer Treat Rep 1982; 66: 1967-4
87. 86. Vik T, Slørdahl S, Moe PJ. An overdose of vineristine in an eleven-year old boy. Eur Paediatr Haematol Oncol 1985; 2: 167-70
88. 87. Wakem CJ, Bennett JM. Inappropriate ADH secretion associated with massive vincristine overdosage. Aust N Z J Med 1975; 5: 266-9
89. 88. Wegelius R. An overdose of vincristine [letter]. Pediatr Hematol Oncol 1987; 4: 173-5
90. 89. Weissman SJ, Berkow RL, Weetman RM, et al. 5-Azacytidine: acute central nervous system toxicity. Am J Pediatr Hematol Oncol 1985; 7: 86-8
91. 90. Williams ME, Walker AN, Bracikowski JP, et al. Ascending myeloencephalopathy due to intrathecal vincristine sulfate: a fatal chemotherapeutic error. Cancer 1983; 51: 2041-7
92. 91. Winter SC, Arbus GS. Syndrome of inappropriate secretion of antidiuretic hormone secondary to vinblastine overdose [letter]. Can Med Assoc J 1977; 117: 1134
93. 92. Yoffe G, Rice L, Alfrey CP Jr., et al. Case report. Depressive reaction to vincristin overdose [letter]. Clin Lab Haematol 1986; 8: 80-1
94. 93. Zaniboni A, Simonìcini E, Marpicati P, et al. Severe delayed neurotoxicity after accidental high-dose nitrogen mustard [letter]. Am J Hematol 1988; 27: 305
95. 94. Zaragoza MR, Ritchey ML, Walter A. Neurologic consequences of accidental intrathecal vincristine: a case report. Med Pediatr Oncol 1995; 24: 61-2
96. 95. Raju TNK, Kecskes S, Thornton JP, et al. Medication errors in neonatal and paediatric intensive-care units. Lancet 1989; 11: 374-6
97. 96. Anonymous. Wisconsin reviews state code on medication error reporting (news). Am J Hosp Pharm 1994; 51: 1145-6
98. 97. Allan EL, Barker KN. Fundamentals of medication error research. Am J Hosp Pharm 1990; 47: 555-71
99. 98. Ness JE, Sullivan SD, Stergachis A. Accuracy of technicians and pharmacists in identifying dispensing errors. Am J Hosp Pharm 1994; 51: 354-7
100. 99. Davis NM, Cohen MR. Purpose of medication will reduce errors. Am Pharm 1992; NS32: 22-3
101. 100. Favier M, de Cazanove F, Saint-Martin F, et al. Preventing medication errors in antineoplastic therapy. Am J Hosp Pharm 1994; 51: 832-3
102. 101. Lesar TS, Briceland LL, Delcoure K, et al. Medication prescribing errors in a teaching hospital. JAMA 1990; 263: 2329-34
103. 102. Anonymous. Cancer doctor resigns. USA TODAY. International ed. Friday, May 12, 3A, 1995
104. 103. Peterson AM, Schwarz LR, Veatch RM. Asking a pharmacist to resign for making an error. Am J Health Syst Pharm 1996; 53: 760-3
105. 104. Manasse HR. Medication use in an imperfect world: drug misadventuring as an issue of public policy. Pt 1. Am J Hosp Pharm 1989; 46: 929-44
106. 105. McCarthy ID, Cohen MR, Kateiva J, et al. What should a pharmacy manager do when a serious medication error occurs?: a panel discussion. Am J Hosp Pharm 1992; 49; 1405-12
107. 106. Fitts PM, Jones RE. Analysis of factors contributing to 460 pilot-error experiences in operating aircraft controls. In: Sinaiko WH, editors. Selected papers on human factors in the design and use of control systems. New York, Dover, 1961
108. 107. Heckhausen H. Intentionsgeleitetes Handeln und seine Fehler. In: Heckhausen H, Gollwitzer PM, Weinert FE, editors. Jenseits des Rubikon: Der Wille in den Humanwissen-schaften. Berlin: Springer, 1987: 143-175
109. 108. Heckhausen H, Beckmann J. Intentional action and action slips. Psychol Rev 1990; 1: 36-48
110. 109. Meister D. Human factors in reliability. In: Ireson WG, editor. Reliability handbook. New York: McGraw-Hill, 1966
111. 110. Reason J, Mycielska K. Absent-minded?: the psychology of mental lapses and everyday errors. Englewood Cliffs: Prentice-Hall, 1982
112. 111. Singleton WT. Theoretical approaches to human error. Ergonomics 1973; 16: 637-727
113. 112. Swain AD, Guttmann HE. Handbook of human reliability analysis with emphasis on nuclear power plant applications. Sandia National Laboratories, NUREG/CR-1278, Washington DC: US Nuclear Regulatory Commission, 1984
114. 113. Wehner T. Sicherheit als Fehlerfreundlichkeit: arbeits-und sozialpsychologische Befunde für eine kritische Technikbewertung. Opladen: Westdeutscher Verlag, 1992
115. 114. Wehner T, Stade M. The cognitive organisation of human errors: a gestalt theory perspective. Appl Psych Int Rev 1994; 43: 565-84
116. 115. Wehner T. Fehler und Fehlhandlungen. In: Luezak H, Volpert W, editors. Handbuch Arbeitswissenschaft. Berlin: Springer, 1993
117. 116. Zimolong B. Fehler und Zuverläßigkeit. In: Hoyos CG, Zimolong B, editors. Ingenieurspsychologie. Göttingen: Hogrefe, 1992
118. 117. Herczeg M, Software Ergonomie. Grundlagen der Mensch-Computer Kommunikation. Bonn: Addison-Wesley, 1994
119. 118. Schmidt RF, Thews G. Physiologie des Menschen. Berlin: Springer, 1995
120. 119. Anderson JR. Cognitive psychology and its implications. New York: Freeman, 1985
121. 120. Koblitz K. Redundanz und Information. Informatik 1969; 16: 5-10
122. 121. Shannon CE, Weaver W. The mathematical theory of communication. Urbana: University of Illinois Press, 1980
123. 122. Wersig G. Information - Kommunikation - Dokumentation. München-Pullach: Verlag Dokumentation, 1971
124. 123. Flynn RR. An introduction to information science. New York: Marcel Dekker, 1987
125. 124. Zornikow B, Michel E, Jacobs C, et al. Kreatives Zeitmanagement im Krankenhaus. Munatsschr Kinderheilkd 1996; 144: 627-35
126. 125. Betz RP, Levy HB. An interdisciplinary method of classifying and monitoring medication errors. Am J Hosp Pharm 1985; 42: 1724-32
127. 126. Cherubim D. Fehlerlinguistik: Beiträge zum Problem der sprachlìchen Abweichung. Tübingen: Niemeyer, 1980
128. 2 test of goodness of fit. Ann Math Statist 1952; 23: 315-45
129. 2 tests. Biometrics 1954; 10: 417-51
130. 129. Siegel S. Non-parametric statistics for the behavioral science. New York: McGraw Hill, 1956
131. 130. Hartwig SC, Denger SD, Schneider PJ. Severity-indexed, incident report-based medication error-reporting program. Am J Hosp Pharm 1991; 48: 2611-6
132. 131. Byrd L. A quality assurance study of medication errors in a psychiatric hospital. Top Health Record Manage 1984; 2: 61-7
133. 132. Fischer DS, Alfuno S, Knohf MT, et al. Improving the cancer chemotherapy use process. J Clin Oncol 1996; 14: 3148-55
134. 133. Folli HL, Poole RL, Benitz WE, et al. Medication error prevention by clinical pharmacists in two children's hospitals. Pediatrics 1987; 79: 718-22
135. 134. Rupp MT. Screening for prescribing errors. Am Pharm 1991; NS31: 71-8
136. 135. Currie M, Mackay P, Morgan C, et al. The 'wrong drug' problem in anaesthesia: an analysis of 2000 incident reports. Anaesth Intensive Care 1993; 21: 596-601
137. 136. Gold DR, Rogacz S, Bock N, et al. Rotating shift work, sleep, and accidents related to sleepiness in hospital nurses. Am J Public Health 1992; 82: 1011-4
138. 137. ASHP guidelines on preventing medication errors in hospitals. Am J Hosp Pharm 1993; 50: 305-14
139. 138. Donchin Y, Gopher D, Olin M, et al. A look into the nature and causes of human errors in the intensive care unit. Crit Care Med 1095; 23: 294-300
140. 139. Fuqua RA, Stevens KR. What we know about medication errors: a literature review. J Nurs Qual Assur 1988; 3: 1-17
141. 140. Davis NM. 1700 medical abbreviations: convenience at the expense of communication and safety. Hosp Pharm 1983; 18: 180-97
142. 141. Davis NM. Teaching patients to prevent errors. Am J Nurs 1994; 94: 17
143. 142. Davis NM, Cohen MR. Learning lessons from dispensing errors. Am Pharm 1994; NS34: 27-8
144. 143. Buchanan TL, On the effect of varying levels of illumination on the prescription dispensing error rate in an army high-volume outpatient pharmacy service. Auburn: Auburn University Press, 1989
145. 144. Allan F.L. Relationship among facility design variables and medication errors in an pharmacy [dissertation]. Auburn: Auburn Universíty, 1994
146. 145. Flynn EA, Barker KN, Gibson JT, et al. Relationship between ambient sounds and accuracy of pharmacists' prescription-filling performance. Hum Factors 1996; 38: 614-22
147. 146. Embrey DE, Humphreys P, Rosa EA, et al. SLIM-MAUD: An approach to assessing human error probabilities using structured expert judgement. Washington DC: US nuclear Regulatory Commission, 1984
148. 147. Graumann CF. Handbuch der Psychologie. Vol. 7. Sozialpsychologie. Göttingen: Hotzgreve, 1972
149. 148. AHFS drug information 92. McEvoy GK, editor. Vincristine sulfate. Bethesda: American Society of Hospital Pharmacists, 1992
150. 149. Davis NM. Cisplatin-carboplatin mix ups: current and future concerns. Hosp Pharm 1994; 29: 1077, 1097
151. 150. Haran C, Rengel AM. Color coding can prevent mishaps. J Ophthal Nurs Technol 1985; 4: 28-9
152. 151. Kusch M, Labouvie H, Bode U. Einflüsse auf die Bewältigung der ersten Behandlungsphase in der pädiatrischen Onkologie, Sozialpädiatrie 1994; 16: 629-35
153. 152. Kusch M, Vetter C, Bode U. Stationäre, psychologische Betreuung: Ein Konzept der behandlungsbegleitenden psychosozialen Versorgung. Praxis Kinderpsychol Kinder psychiatrie 1993; 42: 316-26
154. 153. Biabace R. Individualistic and organizational analyses of informed consent. Fam Syst Med 1991; 9: 297-306
155. 154. Ruccione R, Kramer RF, Moore IK, et al. Informed consent for treatment of childhood cancer: factors affecting parents' decision making. J Pediatr Oncol Nurs 1991; 8: 112-21
156. 155. Bachert A, Schilling F. Computer assisted therapy planning in pediatric oncology. Ann Hematol 1993; 67 Suppl.: A4
157. 156. Berard CM, Mahoney CD, Welch DW, et al. Computer software for pharmacy oncology services. Am J Health Syst Pharm 1996; 53: 752-6
158. 157. Stoner NS, Tanfield CJ, Talbot DC. Computerised prescibing of chemotherapy reduces errors. BMJ 1996; 312: 707
159. 158. Boyce B, Herrier R. Obtaining and using patient information. Am Pharm 1991; NS31: 517-23
160. 159. Thorn DB, Sexton MG, LeMay AP, et al. Effects of a cancer chemotherapy prescription form on prescription completeness. Am J Hosp Pharm 1989; 46: 1802-6
161. 160. Olsen M. Order sheets help prevent chemotherapy administration errors. Oncol Nurs Forum 1997; 24: 802-3
162. 161. Herschbach P. Psychische Belastung von Ärzten und Krankenpflegekräften. Weinheim: VCH Edition Medizin, 1991
163. 162. Norman DA. New views of information processing: implication for intelligent decision support systems. In: Hollnagel E, Mancini G, Woods DD, editors. Intelligent decision support in process environment. Berlin: Springer, 1986
164. 163. Draft guidelines on preventable medication errors. Am J Hosp Pharm 1992; 49: 640-8
165. 164. Moe PJ, Hertz H, Ludvigsson J, et al. Feilmedisinering af cytostatika hosbarn-profytaske og terapi. Nord Med 1986; 101: 223-5
166. 165. Trinkle R, Wu JK. Errors involving pediatric patients receiving chemotherapy: a literature review. Med Pediatr Oncol 1997; 26: 344-51
167. 2. J Clin Oncol 1991; 9: 670-4
168. 167. Dorr R. Chemoprotectants for cancer chemotherapy. Semin Oncol 1991; 18 Suppl. 2: 48-58
169. 168. Thomas LL, Mertens MJ, von-dem-Borne AE, et al. Clinical management of cytotoxic drug overdose. Med Toxicol Adv Drug Exp 1988; 3: 253-63
170. 169 Jardine LF, Ingram LC, Bleyer WA. Intrathecal leucovorin after intrathecal methotrexate overdose. J Pediatr Hematol Oncol 1996; 19: 302-4